GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Shinyak Corp (XKRX:067290) » Definitions » Cyclically Adjusted PS Ratio

JW Shinyak (XKRX:067290) Cyclically Adjusted PS Ratio : 0.81 (As of May. 31, 2024)


View and export this data going back to 2003. Start your Free Trial

What is JW Shinyak Cyclically Adjusted PS Ratio?

As of today (2024-05-31), JW Shinyak's current share price is ₩1740.00. JW Shinyak's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩2,158.16. JW Shinyak's Cyclically Adjusted PS Ratio for today is 0.81.

The historical rank and industry rank for JW Shinyak's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:067290' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.82   Med: 2.33   Max: 5.68
Current: 0.82

During the past years, JW Shinyak's highest Cyclically Adjusted PS Ratio was 5.68. The lowest was 0.82. And the median was 2.33.

XKRX:067290's Cyclically Adjusted PS Ratio is ranked better than
76.75% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.085 vs XKRX:067290: 0.82

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

JW Shinyak's adjusted revenue per share data for the three months ended in Mar. 2024 was ₩470.621. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩2,158.16 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


JW Shinyak Cyclically Adjusted PS Ratio Historical Data

The historical data trend for JW Shinyak's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Shinyak Cyclically Adjusted PS Ratio Chart

JW Shinyak Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 2.86 1.92 1.69 1.15

JW Shinyak Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 1.29 1.18 1.15 0.93

Competitive Comparison of JW Shinyak's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, JW Shinyak's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Shinyak's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Shinyak's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where JW Shinyak's Cyclically Adjusted PS Ratio falls into.



JW Shinyak Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

JW Shinyak's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1740.00/2158.16
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Shinyak's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, JW Shinyak's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=470.621/118.8477*118.8477
=470.621

Current CPI (Mar. 2024) = 118.8477.

JW Shinyak Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 384.891 99.353 460.413
201409 396.141 99.608 472.657
201412 537.331 99.098 644.418
201503 402.338 99.720 479.512
201506 415.030 100.050 493.007
201509 393.680 100.110 467.366
201512 512.487 100.220 607.742
201603 444.254 100.560 525.045
201606 455.426 100.790 537.021
201609 454.435 101.460 532.314
201612 432.485 101.560 506.103
201703 438.245 102.850 506.411
201706 354.809 102.610 410.956
201709 456.668 103.490 524.437
201712 340.064 102.990 392.425
201803 494.404 104.100 564.446
201806 437.560 104.130 499.405
201809 439.897 105.650 494.849
201812 487.486 104.350 555.214
201903 455.013 104.490 517.535
201906 513.324 104.880 581.687
201909 539.557 105.200 609.554
201912 550.888 105.120 622.829
202003 468.758 105.540 527.864
202006 565.117 104.870 640.439
202009 567.611 106.200 635.210
202012 607.921 105.765 683.116
202103 478.553 107.357 529.773
202106 465.995 107.579 514.809
202109 524.913 108.759 573.604
202112 633.935 109.676 686.946
202203 511.904 111.806 544.145
202206 398.934 114.083 415.596
202209 505.379 114.831 523.055
202212 593.065 115.200 611.843
202303 522.920 116.550 533.231
202306 534.028 117.140 541.814
202309 547.733 119.111 546.521
202312 597.654 118.848 597.654
202403 470.621 118.848 470.621

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


JW Shinyak  (XKRX:067290) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


JW Shinyak Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of JW Shinyak's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Shinyak (XKRX:067290) Business Description

Traded in Other Exchanges
N/A
Address
2477, Nambusunhwan-ro, Seocho-gu, Seoul, KOR, 137-864
JW Shinyak Corp is a pharmaceutical company. The company produces and provides high-quality medicine and medical supplies needed in dermatology, urology, pediatrics, otolaryngology. The key products include antibiotics, anesthetics, respiratory drugs, urology drugs, cardiovascular drugs, allergy drugs, digestive drugs, anti-inflammatory drugs, antivirals as well as cosmetic products including creams, cleansers, toners, essences, lotions, among others.

JW Shinyak (XKRX:067290) Headlines

No Headlines